Cited by 196Telomeres, Telomerase, and SenescenceAtherosclerosis and Cardiovascular DiseasesNitric Oxide and Endothelin Effects

The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.

Vascular smooth muscle cell senescence in atherosclerosis

GORENNE, I, KAVURMA, M, SCOTT, S, BENNETT, M·2006·Cardiovascular Research

DOI 10.1016/j.cardiores.2006.06.004

Open this paper in CoChat — free account

Abstract

Markers of cell senescence have been identified in both the blood and vessel wall of patients with atherosclerosis. In particular, vascular smooth muscle cells (VSMCs) derived from human plaques show numerous features of senescence both in culture and in vivo. This review summarises the evidence for VSMC senescence in atherosclerosis, and outlines the mechanisms and triggers leading to their senescence.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.cardiores.2006.06.004

Cites

109 of 109 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“In vitro, SIPS can be elicited by overexpressing Ras and Raf oncogenes [91,92], radiation [93,94], or chemical agents producing any form of DNA damage and oxidant stress [94–97].”
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Lessons From Sudden Coronary Death: A Comprehensive Morphological Classification Scheme for Atherosclerotic Lesions
Virmani, R., Kolodgie, F. D., Burke, A. P., Farb, A., & Schwartz, S. M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.5.1262 · Cited by 4,084
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917 · cited 3×
“Each focus reveals the presence of the DNA repair complexes at the site of DNA damage [88].”
Mammalian Telomeres End in a Large Duplex Loop
Griffith, J. D., Comeau, L., Rosenfield, S., Stansel, R. M., Bianchi, A., Moss, H., & de Lange, T. (1999) · Cell · doi:10.1016/s0092-8674(00)80760-6 · Cited by 2,447
The RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227
Switching and Signaling at the Telomere
Blackburn, E. H. (2001) · Cell · doi:10.1016/s0092-8674(01)00492-5 · Cited by 2,139

Show all 108 references

Research works printed but not linked: 6

[21]21. Stein GH, Dulic V. Origins of G1 arrest in senescent human fibroblasts. Bioessays 1995;17:537-43.
[36]36. Brandes RP, Fleming I, Busse R. Endothelial aging. Cardiovasc Res 2005;66:286-94.
[37]37. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest 1995;95:2266-74.
[41]41. Tanner F, Boehm M, Akyürek L, San H, Yang Z-Y, Tashiro J, et al. Differential effects of the cyclin-dependent kinase inhibitors p27Kip1, p21Cip1 and p16Ink4 on vascular smooth muscle cell proliferation. Circulation 2000;101:2022-5.
[61]61. Blackburn EH. Switching and signaling at the telomere. Cell 2001;106:661-73.
[78]78. Minamino T, Kourembanas S. Mechanisms of telomerase induction during vascular smooth muscle proliferation. Circ Res 2001;89:237-43.

Sorted by citations

Items 101–196 of 196

Environmental carcinogens and mutational pathways in atherosclerosis
Pulliero, A., Godschalk, R., Andreassi, M. G., Curfs, D. M. J., van Schooten, F., & Izzotti, A. (2015) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2015.01.007 · Cited by 37
“007 ranslocations, which promote both genomic and mitochondrial nstability (Gorenne et al., 2006).”
Background
Novel Role for Inhibitor of Differentiation 2 in the Genesis of Angiotensin II–Induced Hypertension
Gratze, P., Dechend, R., Stocker, C., Park, J.-K., Feldt, S., Shagdarsuren, E., Wellner, M., Gueler, F., Rong, S., Groß, V., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.760116 · Cited by 36
Uremic Toxin Indoxyl Sulfate Inhibits Human Vascular Smooth Muscle Cell Proliferation
Mozar, A., Louvet, L., Morlière, P., Godin, C., Boudot, C., Kamel, S., Drüeke, T. B., & Massy, Z. A. (2011) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2010.00885.x · Cited by 29
“In vivo p27 expression is elevated in non-proliferating cells from both normal and atheromatous vessels, whereas p21 expression is elevated only in atherosclerotic plaques (14).”
Background
DNA damage-dependent mechanisms of ageing and disease in the macro- and microvasculature
Shah, A. V., & Bennett, M. R. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.03.050 · Cited by 27
Self-citation
Inhibition of Cardiac Hypertrophy Effects in D‐Galactose‐Induced Senescent Hearts by Alpinate Oxyphyllae Fructus Treatment
Chang, Y., Chang, H., Lin, H.-J., Tsai, C., Tsai, C.-T., Chang, H.-N., Lin, S.-L., PadmaViswanadha, V., Chen, R., & Huang, C. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/2624384 · Cited by 28
MicroRNA-214 modulates the senescence of vascular smooth muscle cells in carotid artery stenosis
Chen, Y., Sheu, J., Sun, C., Huang, T., Lin, Y.-P., & Yip, H. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00167-1 · Cited by 27
Cell senescence: basic mechanisms and the need for computational networks in vascular ageing
Regnault, V., Challande, P., Pinet, F., Li, Z., & Lacolley, P. J. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa318 · Cited by 27
Targeting senescent cells for vascular aging and related diseases
Ding, Y.-N., Wang, H.-Y., Chen, H., & Liu, D. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.08.009 · Cited by 30
Luteolin Inhibits Angiotensin II-Induced Human Umbilical Vein Endothelial Cell Proliferation and Migration Through Downregulation of Src and Akt Phosphorylation
Zhu, M., Chen, D., Li, D., Ding, H., Zhang, T., Xu, T., & Zhang, Y. (2013) · Circulation Journal · doi:10.1253/circj.cj-12-0310 · Cited by 27
Application of Oxidative Stress to a Tissue-Engineered Vascular Aging Model Induces Endothelial Cell Senescence and Activation
Salmon, E. E., Breithaupt, J. J., & Truskey, G. A. (2020) · Cells · doi:10.3390/cells9051292 · Cited by 26
“Senescence-associated β-Galactosidase and cyclin-dependent kinase inhibitor p21 positive vSMCs have been identified within the intima of advanced atherosclerotic plaques [15].”
Background
Myocyte Enhancer Factor 2A Regulates Hydrogen Peroxide‐Induced Senescence of Vascular Smooth Muscle Cells Via microRNA‐143
Zhao, W., Zheng, X., Peng, D., & Zhao, S. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24948 · Cited by 26
“VSMCs in the early passage (passage 4) were treated with PBS (control) or 100mmol/L H2O2 for 24 h to induce VSMC senescence, as previously described (Guo et al., 2007).”
Method
Raman fingerprints as promising markers of cellular senescence and aging
Liendl, L., Grillari, J., & Schosserer, M. (2019) · GeroScience · doi:10.1007/s11357-019-00053-7 · Cited by 24
“gies, which include atherosclerosis (Erusalimsky and Kurz 2005; Gorenne et al. 2006; Minamino 2002; Vasile et al. 2001), osteoporosis (Kassem and Marie”
Background
Connecting vascular aging and frailty in Alzheimer’s disease
Sabbatinelli, J., Ramini, D., Giuliani, A., Recchioni, R., Spazzafumo, L., & Olivieri, F. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111444 · Cited by 23
A Unified Model of Age-Related Cardiovascular Disease
Fossel, M., Bean, J., Khera, N., & Kolonin, M. G. (2022) · Biology · doi:10.3390/biology11121768 · Cited by 24
“Cardiovascular disease is the result of vascular endothelial cell aging [72,73], as well as aging in smooth muscle cells [74,75], cardiomyocytes [76], cardiac fibroblasts [77], and immune cells [78].”
Background
Epigenetic regulation of vascular smooth muscle cell phenotypes in atherosclerosis
Lambert, J., & Jørgensen, H. F. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.119085 · Cited by 28
Vascular Smooth Muscle
Hilenski, L. L., & Griendling, K. K. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2930-6.00003-3 · Cited by 24
Patients with gout have short telomeres compared with healthy participants: association of telomere length with flare frequency and cardiovascular disease in gout
Vazirpanah, N., Kienhorst, L. B. E., van Lochem, E. G., Wichers, C. G. K., Rossato, M., Shiels, P. G., Dalbeth, N., Stamp, L. K., Merriman, T. R., Janssen, M., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210538 · Cited by 23
Ascorbic acid extends replicative life span of human embryonic fibroblast by reducing DNA and mitochondrial damages
Hwang, W.-S., Park, S.-H., Kim, H.-S., Kang, H.-J., Kim, M.-J., Oh, S.-J., Park, J.-B., Kim, J., Kim, S. C., & Lee, J.-Y. (2007) · Nutrition Research and Practice · doi:10.4162/nrp.2007.1.2.105 · Cited by 21
“Further western blot analysis showed that ascorbic acid treatment decreased levels of p53, phospho-p53 at ser 15, and p21, indicating that ascorbic acid relieved senescence-related G1 arrest.”
Function of telomere in aging and age related diseases
Erdem, H. B., Bahsi, T., & Ergün, M. A. (2021) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2021.103641 · Cited by 20
Vascular smooth muscle cell polyploidy: An adaptive or maladaptive response?
McCrann, D. J., Nguyen, H. G., Jones, M. R., & Ravid, K. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21363 · Cited by 21
“Not unexpectedly, regulators and inducers of VSMC ploidy, AngII, oxidative stress, DNA damage, and telomeric shortening have also been associated with cellular senescence (Gupta, 2000; Gorla et al., 2001; Kunieda et al., 2006; Matthews et al., 2006).”
BackgroundInfluential
The role of senescence in the pathogenesis of atrial fibrillation: A target process for health improvement and drug development
Guo, G., Watterson, S., Zhang, S., Bjourson, A. J., McGilligan, V., Peace, A. J., & Singh, T. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101363 · Cited by 22
Selective Clearance of Senescent Chondrocytes in Osteoarthritis by Targeting Excitatory Amino Acid Transporter Protein 1 to Induce Ferroptosis
Wen, Z., Xia, G., Liang, C., Wang, X., Huang, J., Zhang, L., Shan, D., Song, W. C., & Cao, X. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0141 · Cited by 22
“…with aging can promote degenerative pathological changes in the tissues, thus leading to multiple ARDs, such as neurode-generation (Bitto et al, 2010), OA (Shane Anderson and Loeser, 2010), cardiovascular diseases (Gorenne et al, 2006), and decreased insulin sensitivity (Xu et al, 2015).”
Cell‐specific insulin resistance: implications for atherosclerosis
Rajwani, A., Cubbon, R. M., & Wheatcroft, S. B. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2336 · Cited by 20
Restoring extracellular matrix synthesis in senescent stem cells
Rong, N., Mistriotis, P., Wang, X., Tseropoulos, G., Rajabian, N., Zhang, Y., Wang, J., Liu, S., & Andreadis, S. T. (2019) · The FASEB Journal · doi:10.1096/fj.201900377r · Cited by 19
p53 Regulates Mitochondrial Dynamics in Vascular Smooth Muscle Cell Calcification
Phadwal, K., Tang, Q., Luijten, I. H. N., Zhao, J., CORCORAN, B. M., Semple, R. K., Ganley, I. G., & MacRae, V. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021643 · Cited by 21
“Furthermore, VSMCs cultured from human calcified atherosclerotic plaques show a senescent phenotype [33], and it has been proposed that the senescence VSMCs could be the potential cause of plaque rupture [34].”
Background
MicroRNAs and Cardiovascular Disease
Fernandez-Hernando, C. F., & Baldán, Á. (2013) · Current Genetic Medicine Reports · doi:10.1007/s40142-013-0008-4 · Cited by 19
“Williams–Beuren syndrome (WBS), which is characterized for mutations in the elastin gene [28–31].”
Background
Effects of estrogen on stress-induced premature senescence of vascular smooth muscle cells: A novel mechanism for the “time window theory” of menopausal hormone therapy
Zhu, C., Zhang, L., Zheng, Y., Xu, J. L., Song, J., Rolfe, B. E., & Campbell, J. H. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.12.025 · Cited by 19
Luteolin Inhibits Angiotensin II-Stimulated VSMC Proliferation and Migration through Downregulation of Akt Phosphorylation
Xu, T., Zhu, H., Li, D., Lang, Y., Cao, L., Yang, L., Wu, W., & Chen, D. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/931782 · Cited by 18
“Abnormal VSMCs proliferation and migration have been implicated in a number of cardiovascular pathologies, including the pathogenesis of hypertension, the development of restenosis after percutaneous coronary intervention (PCI), and the progression of AS [4, 5].”
Background
Senescent endothelial cells’ response to the degradation of bioresorbable scaffold induces intimal dysfunction accelerating in-stent restenosis
Liu, W., Huang, J., He, S., Du, R., Shi, W., Wang, Y., Du, D., Du, D., Liu, Q., Wang, Y., et al. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.05.028 · Cited by 18
Effects of ginsenoside Rg1 on the senescence of vascular smooth muscle cells
Li, S. G., Yan, M., Zhang, D., Ye, M., & Deng, J. J. (2016) · Genetics and Molecular Research · doi:10.4238/gmr.15038409 · Cited by 17
“Vascular smooth muscle cell (VSMC) senescence plays an important role in the pathogenesis of atherosclerosis (Gorenne et al., 2006).”
Background
Mesoglycan attenuates VSMC proliferation through activation of AMP-activated protein kinase and mTOR
Lee, K. Y., Lee, D. H., & Choi, H. C. (2015) · Clinical Hypertension · doi:10.1186/s40885-016-0037-x · Cited by 16
POT1 and Damage Response Malfunction Trigger Acquisition of Somatic Activating Mutations in the VEGF Pathway in Cardiac Angiosarcomas
Calvete, O., García‐Pavía, P., Domínguez, F., Mosteiro, L., Pérez‐Cabornero, L., Cantalapiedra, D., Zorio, E., y Cajal, T. R., Crespo‐Leiro, M. G., Teulé, À., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012875 · Cited by 15
“A similar mechanism was proposed to explain how short telomeres can lead to vascular senescence and diminished proliferative capacity that involved exhaustion of cell pools in mice.(27,28) In addition, tumor tissue of POT1 p.”
Background
The effects of myocyte enhancer factor 2A gene on the proliferation, migration and phenotype of vascular smooth muscle cells
Zhao, W., Zhao, S., & Peng, D. (2011) · Cell Biochemistry and Function · doi:10.1002/cbf.1823 · Cited by 15
“Thus, the heterogeneity and phenotypic switching of VSMCs may be associated with atherosclerosis (AS).(7) However, the genetic basis of the phenotypic switching of VSMCs remains largely unknown.”
Background
Dual effects of estrogen on vascular smooth muscle cells: Receptor-mediated proliferative vs. metabolite-induced pro-senescent actions
Zhang, L., Zhu, C., Zhang, X., Wan, Y., & Song, J. (2010) · Steroids · doi:10.1016/j.steroids.2010.12.002 · Cited by 15
SIRT-associated attenuation of cellular senescence in vascular wall
Sazdova, I., Hadzi‐Petrushev, N., Keremidarska‐Markova, M., Stojchevski, R., Sopi, R., Shileiko, S. A., Mitrokhin, V. M., Gagov, H., Avtanski, D. B., Lubomirov, L. T., et al. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111943 · Cited by 16
Inflammatory process in atherogenesis: New facts about old flame
Vučević, D. B., Radak, D. J., Radosavljević, T. S., Mladenović, D. R., & Milovanović, I. (2012) · Medicinski pregled · doi:10.2298/mpns1210388v · Cited by 14
“Poznato je da su i bazni faktor rasta fibroblasta (bFGF® basic fibroblast growth factor), kao i epitelni faktor rasta koji vezuje heparin (HBEGF – heparin binding epithelial growth factor) snažni aktivatori proliferacije i migracije VGMĆ [24].”
BackgroundInfluential
Inhibition of estrogen related receptor α attenuates vascular smooth muscle cell proliferation and migration by regulating RhoA/p27 Kip1 and β-Catenin/Wnt4 signaling pathway
Li, Q., Zhu, L., Zhang, L., Chen, H., Zhu, Y., Du, Y., Zhong, W., Zhong, M., & Shi, X. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.02.020 · Cited by 13
“The expression and activity of cell cycle checkpoint proteins including cyclins and Cdks, regulates the transition through the cell cycle (Gorenne et al., 2006).”
Dedifferentiation- and aging-induced loss of mechanical contractility and polarity in vascular smooth muscle cells: Heterogeneous changes in macroscopic and microscopic behavior of cells in serial passage culture
NAGAYAMA, K., NOGAMI, K., SUGANO, S., & Nakazawa, M. (2024) · Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials · doi:10.1016/j.jmbbm.2024.106744 · Cited by 11
Foam cell origination from degenerated vascular smooth muscle cells in atherosclerosis: An ultrastructural study on hyperlipidemic rabbits
Ru, Y., Shang, H., Dong, S., Zhao, S., Liang, H., & Zhu, C. (2020) · Ultrastructural Pathology · doi:10.1080/01913123.2019.1711481 · Cited by 11
Fisetin as a multifunctional bioactive flavonoid: A comprehensive review of its pharmacology, mechanism of action, safety profile, clinical trials, and future directions in therapeutics
Khan, S., Khan, M. M., Badruddeen, B., Ahmad, U., & Khan, S. A. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107620 · Cited by 14
Targeted Therapeutics Delivery by Exploiting Biophysical Properties of Senescent Cells
Low, J., Chan, B., & Tay, A. K. P. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202107990 · Cited by 11
Effect of extracts from Radix Ginseng, Radix Notoginseng and Rhizoma Chuanxiong on delaying aging of vascular smooth muscle cells in aged rats
Tao, L.-L., Lei, Y., Wang, G., Zhu, L., & Wang, Y. (2012) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-012-1180-1 · Cited by 10
Senescent cells in the development of cardiometabolic disease
Postmus, A. C., Sturmlechner, I., Jonker, J. W., van Deursen, J. M., van de Sluis, B., & Kruit, J. K. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000602 · Cited by 10
Vascular smooth muscle cells and monocyte–macrophages accomplice in the accelerated atherosclerosis of insulin resistance states
Fadini, G. P., & Ciciliot, S. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu144 · Cited by 10
“However, VSMCs from human atherosclerotic vessels are senescent and intrinsically prone to apoptosis.(2,3) In fact, when”
Background
Is Senolytic Therapy in Cardiovascular Diseases Ready for Translation to Clinics?
Yang, Z., Potenza, D. M., & Ming, X. (2025) · Biomolecules · doi:10.3390/biom15040545 · Cited by 10
Novel regulations of MEF2-A, MEF2-D, and CACNA1S in the functional incompetence of adipose-derived mesenchymal stem cells by induced indoxyl sulfate in chronic kidney disease
Do, D. T., Phan, N. N., Wang, C., Sun, Z., & Lin, Y.-C. (2016) · Cytotechnology · doi:10.1007/s10616-016-9983-0 · Cited by 9
Research Article Atherosclerosis: analysis of the eNOS (T786C) gene polymorphism.
Barbosa, A. M., Silva, K. S. F., Lagares, M. H., Rodrigues, D. A., da Costa, I. R., de Morais, M. P., Martins, J. V. M., Mascarenhas, R. S., Campedelli, F. L., & Moura, K. K. V. O. (2017) · Genetics and Molecular Research · doi:10.4238/gmr16039708 · Cited by 9
Advanced in Molecular Mechanisms of Atherosclerosis: From Lipids to Inflammation
Meiliana, A., Dewi, N. M., & Wijaya, A. (2018) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v10i2.479 · Cited by 11
Phloretin Inhibits Platelet-derived Growth Factor-BB–induced Rat Aortic Smooth Muscle Cell Proliferation, Migration, and Neointimal Formation After Carotid Injury
Wang, D., Wang, Q., Yan, G., Qiao, Y., & Tang, C. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000213 · Cited by 8
“CDK2 and CDK4 are key mediators during the G0/G1 to S phase progression of the cell cycle and form complexes with cyclin E and cyclin D1, respectively.(32) Cyclin-dependent kinase (CDK)–cyclin complexes phosphorylate Rb resulting in dissociation of the p-Rb/E2F complex, and the E2F transcription factor reactivates for…”
Background
The mechanisms of Chr.9p21.3 risk locus in coronary artery disease: where are we today?
Ruotsalainen, A., Kettunen, S., Suoranta, T., Kaikkonen, M. U., Ylä‐Herttuala, S., & Aherrahrou, R. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00580.2024 · Cited by 6
Melatonin attenuates atherosclerotic plaque vulnerability through SIRT6-dependent regulation of vascular smooth muscle cells senescence
Wang, Y., Zhao, W., Zhang, L., Guo, P., Zou, Y., Qin, Z., Wang, Y., & Wu, X. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103939 · Cited by 7
“VSMC senescence has emerged as a critical contributor to plaque vulnerability through multiple mechanisms, including impaired extra-cellular matrix synthesis, increased secretion of pro-inflammatory mediators, and the promotion of a local microenvironment conducive to plaque rupture [4,25,26].”
Serum Arginase II level can be a novel indicator for erectile dysfunction in patients with vasculogenic erectile dysfunction: a comparative study
Wahed, A. S. A. H. A., Amer, M. A. M., Mohamed, N. M. A., Mobasher, M. O. I., Mamdouh, H., Din, S. F. G., & ElSheemy, M. S. (2018) · International Urology and Nephrology · doi:10.1007/s11255-018-1921-y · Cited by 7
Senescent endothelial cells: key commanders of the cellular communication network within atherosclerotic plaques
Xie, F., Xi, C., Bao, G., Yang, B., Zheng, X., Fu, B., & Zheng, Z. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1712974 · Cited by 8
Senescence-associated alterations in histone H3 modifications, HP1 alpha levels and distribution, and in the transcriptome of vascular smooth muscle cells in different types of senescence
Gadecka, A., Koblowska, M., Kossowska, H., Iwanicka‐Nowicka, R., Janiszewska, D., Mosieniak, G., Bojakowski, K., Goryca, K., & Bielak-Żmijewska, A. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02315-8 · Cited by 6
“Senescence of VSMCs is involved in atherosclerosis progression and plays a critical role in the formation and stabilization of atherosclerotic plaques [39].”
Down‐regulation of Suv39h1 attenuates neointima formation after carotid artery injury in diabetic rats
Zhang, J., Yang, J., Xu, C., Hu, Q. Z., Hu, J. X., Chen, J., & Jiang, H. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14809 · Cited by 6
Progeria‐based vascular model identifies networks associated with cardiovascular aging and disease
Ngubo, M., Chen, Z., McDonald, D., Karimpour, R., Shrestha, A., Yockell‐Lelièvre, J., Laurent, A., Besong, O. T. O., Tsai, E. C., Dilworth, F. J., et al. (2024) · Aging Cell · doi:10.1111/acel.14150 · Cited by 6
“…vascular smooth muscle cells (VSMCs) is a critical component underlying vascular calcification and atherogenesis during aging, whereby the vasculature undergoes significant remodeling in response to increased reactive oxygen species (ROS) and inflammatory cytokine secretion (Gorenne et al., 2006).”
Background
Coronary endothelial function and vascular smooth muscle proliferation are programmed by early-gestation dexamethasone exposure in sheep
Volk, K. A., Roghair, R. D., Jung, F., SCHOLZ, T. D., Lamb, F. S., & Segar, J. L. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00824.2009 · Cited by 6
Real‐Time Monitoring of Atherosclerotic Plaque Using β‐Galactosidase‐Activated Photoacoustic Tomography
Zhou, Y., Yang, H., Deng, H., Zhang, F., Jiang, J., Yang, S., Sun, X., Wu, J., Li, Y., Jin, H., et al. (2025) · Small · doi:10.1002/smll.202506731 · Cited by 6
Remnant like particles may induce atherosclerosis via accelerating endothelial progenitor cells senescence.
Pu, D.-R., & Liu, L. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2006.11.046 · Cited by 4
Sirtuins and chemokines as markers of replicative and induced senescence of human endotheliocytes
Savitskiy, D. V., Linkova, N. S., Kozhevnikova, E. O., Kozlov, K. L., Paltseva, E. M., & Kvetnaia, T. V. (2022) · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · doi:10.29413/abs.2022-7.5-2.2 · Cited by 5
DR1 activation reduces the proliferation of vascular smooth muscle cells by JNK/c-Jun dependent increasing of Prx3
Chen, J., Shi, S., Cai, X., Li, H., Wang, L., Li, H., & Xu, C. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3164-0 · Cited by 5
Arginase II: Atherogenesis Beyond Enzyme Activity
Pandey, D., Romer, L. H., & Berkowitz, D. E. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000392 · Cited by 5
“Apoptosis and senescence of VSMC promote plaque rupture in late-stage atherosclerotic vessels.(1) The mechanisms involved in this process are still unclear and are under active investigation.”
Background
Morphological and Molecular-Biological Changes in the Coronary Arteries after Stenting
Todorov, S. S., Deribas, V. Y., Kazmin, A. S., & Todorov, S. S. (2021) · Kardiologiia · doi:10.18087/cardio.2021.7.n1211 · Cited by 4
The senescent marker p16INK4a enhances macrophage foam cells formation
Siew, W. S., Tang, Y.-Q., Goh, B. H., & Yap, W. H. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09946-z · Cited by 4
Role of the mechanisms of replicative cellular senescence in structural and functional changes of the vascular wall in chronic kidney disease
Rudenko, T. E., Bobkova, I. N., Kamyshova, E. S., & Горелова, И. А. (2017) · Terapevticheskii arkhiv · doi:10.17116/terarkh2017896102-109 · Cited by 3
Leukocyte Telomere Length Shortening Implies Plaque Instability and Major Adverse Cardiovascular Events in Patients With Angiographically Intermediate Lesions
Zhang, A., Li, F., Bao, X., Xu, Z., Yin, Z., Yang, Z., Zhang, J., Gu, J. F., Chang, A. C. Y., Fan, Y., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.812363 · Cited by 3
“An increase in apoptosis and a decrease in proliferation of vascular smooth muscle cells result in fibrous caps thinning and plaque instability (23).”
Background
Targeting Senescent Cells to Improve Human Health
Wijshake, T., & van Deursen, J. M. A. (2016) · Healthy ageing and longevity · doi:10.1007/978-3-319-26239-0_16 · Cited by 3
“For instance, cells with senescent properties accumulate in human heart tissue with aging and senescent vascular smooth muscle cells have been observed in human atherosclerotic plaques (Krishnamurthy et al. 2004; Erusalimsky and Kurz 2005; Gorenne et al. 2006).”
Background
The association of leukocyte telomere length and intermediate coronary lesions—a retrospective study
Zhang, A., Li, F., Sun, T., Fan, Y., Xu, Z., Yin, Z., Yang, Z., Zhang, J., Gu, J. F., Chang, A. C. Y., et al. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-2295 · Cited by 1
Increased expression of inflammation cytokines in senescent vascular smooth muscle cells by balloon catheter denudation is associated with NF-[kappa]B pathway
Zongjie, Q., Qiu, L., Chuan-shi, X., Tong, S., & Yunfei, B. (2008) · 中国人民解放军军医大学学报：英文版 · doi:10.1016/s1000-1948(09)60003-4 · Cited by 2
More than 50 Years of Cellular Senescence: From In Vitro Model to Potential Drug Target?
Schosserer, M., & Grillari, J. (2014) · Journal of Gerontology & Geriatric Research · doi:10.4172/2167-7182.1000e131 · Cited by 2
Macrophage-mediated mechanisms in atherosclerosis: still tangled
Ye, F., Wang, J.-A., Daugherty, A., & Lu, H. S. (2017) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000410 · Cited by 2
Aging and Cardiovascular Diseases: The Role of Cellular Senescence
Bozaykut, P. (2019) · Springer eBooks · doi:10.1007/978-981-13-8273-4_10 · Cited by 3
iPSC Disease Modeling of Laminopathies
Liu, G., Yang, J., Ding, Z., Ocampo, A., Qu, J. T., Suzuki, K., & Belmonte, J. C. I. (2016) · Springer eBooks · doi:10.1007/978-4-431-55966-5_5 · Cited by 1
Immunesenescence and Compromised Removal of Senescent Cells: Implications for Health in Old Age
Hazeldine, J., & Lord, J. M. (2021) · Healthy ageing and longevity · doi:10.1007/978-3-030-87532-9_3 · Cited by 1
The role of targeting cell senescence in vascular diseases and its potential application
Wang, H.-Y., Ding, Y.-N., Wei, Z., Chen, H., & Liu, D. (2022) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0279 · Cited by 1
Research Article The eNOS T786C polymorphism is not related to atherosclerosis and cofactors in a Brazilian population
Oliveira, F. R. B., Corrêa, J. F., Silva, K. S. F., da Costa, I. R., Mascarenhas, R. S., Barbosa, A. M., Lagares, M. H., Campedelli, F. L., & Moura, K. K. V. O. (2019) · Genetics and Molecular Research · doi:10.4238/gmr18269 · Cited by 1
Vascular diseases
Katsuumi, G., & Minamino, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00007-9 · Cited by 1
Regulation of SRF Activity by the ATP-dependent Chromatin Remodeling Enzyme, CHD8
Rodenberg, J. M. (2009) · doi:10.7912/c2/1984
Telomery i telomeraza - starzenie komórkowe - nagroda Nobla z fizjologii lub medycyny 2009
Sikora, E. (2010)
Aging of the Vasculature and Related Systems
Marı́n-Garcı́a, J., Goldenthal, M. J., & Moe, G. W. P. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-74072-0_5
CALL FOR PAPERS Cardiovascular and Cerebrovascular Aging—New Mechanisms and Insights Age-related loss of SirT1 expression results in dysregulated human vascular smooth muscle cell function
Thompson, A. M., Wagner, R. J., & Rzucidlo, E. M. (2014)
Heart Involvement in Osteoarthritis
Courties, A., & Sellam, J. (2017) · Technical report · doi:10.1016/b978-0-12-803997-7.00019-3
Lysosomal oxidation of Low Density Lipoproteins
Ahmad, F. (2017) · CentAUR (University of Reading)
Bedeutung von Seneszenz im abdominellen Aortenaneurysma
Hofmann, A., Horn, F., Wolk, S., & Reeps, C. (2021) · Gefässchirurgie · doi:10.1007/s00772-021-00794-w
Comparación del fenotipo secretor asociado a la senescencia en dos formas distintas de senescencia prematura inducida
Maciel-Barón, L. Á. (2014) · doi:10.24275/uami.ws859f759
Cellular mechanisms of aging and their impact on the aortic/arterial wall
Arefin, S., Laučytė-Cibulskienė, A., Hobson, S., Schwarz, A., Dai, L., Kublickiene, K. R., & Stenvinkel, P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91391-1.00025-x
1 0 7
Georgakilas, A. G. (2012) · CRC Press eBooks · doi:10.1201/b14318-8
AGE
(2013) · AGE · doi:10.1007/11357.1574-4647
Impairing Senohemostasis by Ablating DPP4 Improves AtherosclerosisPreprint
Herman, A. B., Tsitsipatis, D., Anerillas, C., Mazan-Mamczarz, K., Carr, A. E., Gregg, J. M., Wang, M., Zhang, J., Michel, M., Harris, S. C., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4186256
Can age be a modifiable risk factor? the impact of dietary patterns on the molecular mechanisms that underlie cardiovascular aging
Lewis, S. A., Britt, W. M., Koch, R. L., Razavi, A. C., Patel, P., Sperling, L. S., & Souza, M. S. D. (2023) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2023.1 · Cited by 1
The Relationship Between Genetic Variants at Loci 9p21, 6q25.1, and 2q36.3 and the Development of Cardiac Allograft Vasculopathy in Heart Transplant Patients
Dlouhá, D., Janoušková, K., Vymětalová, J., Nováková, Š., Chytilová, Š., Lukášová, M., & Hubacek, J. A. (2025) · Genes · doi:10.3390/genes16020236
Nomogram for Predicting Regression of Persistent Coronary Artery Aneurysms in Kawasaki Disease: A Three-year Follow-up Cohort Study in Southwest China
Liang, K., Pang, Y., & Su, D. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s560947
Effets d’une exposition chronique au césium 137 à faibles doses sur la progression de l’athérosclérose
Gallic, C. L. (2015) · theses.fr (ABES) · doi:10.70675/71430d4dz07cez4cc3za153ze7c0b63eada2
Rôle des élastokines et impact de leur carbamylation au cours du vieillissement vasculaire
Henry, A. (2022) · doi:10.70675/70ebea76z1bc5z4a8czbfaczbb61d765b235
Selective targeting of cancer and senescence via shared metabolic shifts extends lifespan of old mice
Robinson, Z. R., Fong, S. C., Choi, D. Y., Siopack, S., Bolanos-Campos, A., Morshedian, N., Utke, E., Kanda, M., Kato, C., Conboy, M. J., et al. (2026) · Aging · doi:10.18632/aging.206399
“Moreover, excess senescence is correlated with numerous other age-related diseases [7, 11 – 21], so senescent cell removal is hypothesized to enhance overall health.”
Intracranial aneurysms as a manifestation of premature vascular aging: Cellular senescence, inflammaging, and wall degeneration
Maeda, T., Sato, H., NAKANO, Y., Kobayashi, H., Take, Y., Nisson, P. L., Cisneros, O., Rahmani, R., Jackson, B., Castro, J. C., et al. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103341

Authors: GORENNE, I., KAVURMA, M., SCOTT, S., & BENNETT, M.
Affiliations: University of Cambridge (GB)
Corresponding author: BENNETT, M
ORCID: KAVURMA, M
BENNETT, M
Venue: Cardiovascular Research
Publisher: Oxford University Press (OUP)
Published: 2006-10-01
Volume: 72
Issue: 1
Pages: 9-17
ISSN: 0008-6363 (ISSN-L)
DOI: 10.1016/j.cardiores.2006.06.004
OpenAlex: W2155554546
Cited by: 196
References: 108
Citations by year: 2026: 4 · 2025: 8 · 2024: 11 · 2023: 7 · 2022: 14 · 2021: 15 · 2020: 13 · 2019: 14 · 2018: 9 · 2017: 16 · 2016: 11 · 2015: 12 · 2014: 11 · 2013: 12 · 2012: 8
FWCI: 0.62
Type: journal article
Language: en
Open access: closed
Locations: Cardiovascular Research (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
Keywords: vascular smooth muscle cells, cellular senescence, atherosclerosis, atherosclerotic plaque, senescence markers, senescence mechanisms, plaque macrophages
MeSH terms: beta-Galactosidase, Cell Cycle, Humans, Muscle, Smooth, Vascular, Telomere, Cellular Senescence, Cell Proliferation, Atherosclerosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Vascular smooth muscle cell senescence in atherosclerosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks